Sunny Pharmtech (6676.TWO) Action Cours

Sunny Pharmtech Inc, listed on the Taiwan Stock Exchange with ticker 6676.TWO and ISIN TW0006676000, is a pharmaceutical company headquartered in Taoyuan, Taiwan. The company specializes in the development, manufacturing, and marketing of generic and 505(b)2 drug products. It went public through an IPO on January 19, 2022. Sunny Pharmtech employs 123 full-time staff members. The company's product portfolio includes a range of pharmaceuticals, such as LDC anesthesia analgesic ointment, NFT anti-urinary tract infection capsules, AMA hemostatic lozenges, CYA injections for anemia, and CPT gynecological injections. These products are primarily marketed and sold in the United States. The company's website is www.sunnypharmtech.com. Sunny Pharmtech operates within the health care sector, specifically in the pharmaceuticals industry, focusing on generic and specialty drug solutions. Its operational focus is on developing and distributing pharmaceutical products that address specific medical needs, with a significant market presence in the U.S. market. The company's current structure and operations reflect a commitment to pharmaceutical innovation within a niche segment of the industry.